Orchard Therapeutics has revealed its US pricing plans for Lenmeldy, its gene therapy for metachromatic leukodystrophy (MLD), placing a $4.25 million price tag on the one-shot treatment.

The endorsement doesn’t mean Charlotte will host the games. But if selected, the event could bring $3 billion in revenue to the state, according to one estimate. Real-time updates and all local ...

“For me, it represents our legacy, it represents the ability, even in the most difficult situations, to come together as a unit and make something work.” ...